'On consolidated basis
Quarter ended December 2024 compared with Quarter ended December 2023.
Net sales (including other operating income) of Divis Laboratories has increased 25.01% to Rs 2319 crore. Operating profit margin has jumped from 26.36% to 32.04%, leading to 51.94% rise in operating profit to Rs 743.00 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 41.35% to 42.22%. Employee cost decreased from 13.96% to 12.28%. Other expenses fell from 19.22% to 14.76%.
Other income fell 13.68% to Rs 82 crore. PBIDT rose 41.27% to Rs 825 crore. Provision for interest remained nil.
PBDT rose 41.27% to Rs 825 crore. Provision for depreciation rose 4.21% to Rs 99 crore.
Profit before tax grew 48.47% to Rs 726.00 crore. Share of profit/loss were nil in both the periods. Prov...
Pleaselogin & subscribe to view the full report.
More Reports
|
|